Eaze Raises $13 Million for Its Marijuana Delivery Startup

As David Chao walks into the glass conference room, there’s nothing unusual about him as an investor. He’s tall, middle-aged with dark hair and clutching the expected techie accessory: a smartphone.

But there’s one unusual detail about Chao: He’s a medical marijuana user.

Chao first gave cannabis a try a couple of years ago, after a cycle of painful stomach and lung problems he couldn’t relieve through traditional medicine. One day, as they sat around playing video games, pal Blake Krikorian, a co-founder of Sling Media who recently died of a heart attack, suggested Chao look into alternative treatments such as medical marijuana.

“I actually got a prescription and I tried—since I still can’t smoke—half of a 10-milligram chocolate,” Chao told Fortune of his first taste of medical marijuana. Because of asthma, Chao was prescribed cannabis in the form of a chocolate instead of smokeable formats.

“Within an hour and a half, it took the edge off my pain,” he said, adding that the dose was small enough that it soothed him but he was far from being high on the drug.

Continue reading this story at Fortune.